PrednisoneProtein PrecursorsVincristineCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsAmyloid beta-Protein PrecursorMechlorethaminePrednisoloneAzathioprineImmunosuppressive AgentsTreatment OutcomeMelphalanMitoxantroneAntibodies, Monoclonal, Murine-DerivedDrug Therapy, CombinationEnzyme PrecursorsAnti-Inflammatory AgentsDrug Administration ScheduleBleomycinRNA PrecursorsMethotrexateColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinCyclosporineHodgkin DiseaseLymphoma, Large B-Cell, DiffuseMycophenolic AcidTime FactorsMolecular Sequence DataNucleic Acid PrecursorsVinblastineAsparaginaseMultiple MyelomaAdministration, OralAdrenal Cortex HormonesFollow-Up StudiesAmyloid Precursor Protein SecretasesThalidomideKidney TransplantationAmino Acid SequenceEtoposideCell DifferentiationSurvival AnalysisRecurrenceGraft RejectionProtein Processing, Post-TranslationalDisease-Free SurvivalTacrolimusMethylprednisoloneBase SequenceSurvival RateStem CellsCombined Modality TherapyNephrotic SyndromePrecursor Cell Lymphoblastic Leukemia-LymphomaDose-Response Relationship, Drug6-MercaptopurineEtiocholanoloneCyclosporinsPolymyalgia RheumaticaAntibodies, MonoclonalLymphoma, FollicularClinical Trials as TopicCarmustineAndrostenolsVindesinePrognosisDexamethasoneTaxoidsImmunosuppressionProspective StudiesCells, CulturedDouble-Blind MethodRetrospective StudiesCapillary FragilityBoronic AcidsLomustineGraft SurvivalArthritis, RheumatoidEstramustineProstatic NeoplasmsAntineoplastic Agents, HormonalPyrazinesRemission, SpontaneousThrombocytopeniaFluoxymesteroneMutationOrchiectomy